As of 2025-07-03, the Relative Valuation of Impel Neuropharma Inc (IMPL) is (302.53) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.24 USD, the upside of Impel Neuropharma Inc based on Relative Valuation is -125577.7%.
The range of the Relative Valuation is (296.98) - (421.69) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.9x - 18.3x | 12.9x |
| Forward P/E multiples | 12.5x - 20.7x | 13.3x |
| Fair Price | (296.98) - (421.69) | (302.53) |
| Upside | -123278.9% - -175002.5% | -125577.7% |
| Date | P/E |